Pharmstandard International S.A., 10% Owner at ARGOS THERAPEUTICS INC (ARGS), bought 67,371 shares at $4.36 ($305K) on 2016-08-23, disclosed to the SEC on 2016-08-25.
Open-market purchase of $305k ARGS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.36 | 9,599 | $42K | 13.7% |
| 2 | $4.55 | 57,772 | $263K | 86.3% |
| Total | $4.52 avg | 67,371 | $305K | 100% |
| Filing → |
| ARGS | BUY | 2016-09-07 | $162K | — | Filing → |
| ARGS | BUY | 2016-08-29 | $252K | — | Filing → |
| ARGS | BUY | 2016-08-23 | $320K | — | Filing → |